Table 3.
Serum phosphate levels and all-cause mortality in RS-I and RS-II, adjusted for age, BMI and smoking, follow-up until year 2012
Men | Women | |||||
---|---|---|---|---|---|---|
no events | HR* (95% CI) | p | no events | HR* (95% CI) | p | |
RS-I | 810/1577 | 1.58 (1.34–1.87) | < 0.001 | 821/2154 | 0.85 (0.71–1.00) | 0.056 |
RS-II | 262/1133 | 1.14 (0.85–1.53) | 0.378 | 207/1361 | 1.14 (0.81–1.60) | 0.439 |
Studies combined† | 1072/2710 | 1.46 (1.26–1.69) | < 0.001 | 1028/3515 | 0.90 (0.77–1.05) | 0.176 |
Statistically significant p-values (<0.05) are highlighted in bold font
*Hazard ratios from Weibull models, expressed per 1 mg/dL (0.32 mmol/L) increase in phosphate levels
†Studies combined from meta-analyses using fixed-effect models